Indication

Lymphomatous meningitis

Lymphomatous meningitis is a severe neuro-oncologic manifestation characterized by the dissemination and infiltration of malignant lymphoid cells into the leptomeninges and cerebrospinal fluid compartments of the central nervous system. Read more about Lymphomatous meningitis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Lymphomatous meningitis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Lymphomatous meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Lymphomatous meningitis.

Lymphomatous meningitis is a severe neuro-oncologic manifestation characterized by the dissemination and infiltration of malignant lymphoid cells into the leptomeninges and cerebrospinal fluid compartments of the central nervous system.

It primarily occurs as a secondary metastatic complication of aggressive systemic non-Hodgkin lymphomas, though it can also arise in the setting of primary central nervous system lymphoma.

Pathophysiologically, the tumor cells seed the subarachnoid space, disrupting cerebrospinal fluid dynamics and prompting multifocal inflammation across the entire neuraxis.

This diffuse involvement leads to varied neurological deficits, typically presenting with combinations of cranial neuropathies, radicular pain or motor weakness, altered mental status, and symptoms of elevated intracranial pressure such as persistent headache, nausea, and vomiting.

Personalize your experience

Follow Lymphomatous meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it